AZTREONAM
SEPSIS CAUSED BY ENTEROBACTER·+57
APP PHARMACEUTI
Indication
Proteus bronchitis
Proteus bronchitis refers to a lower respiratory tract infection characterized by acute inflammation of the tracheobronchial tree caused by Gram-negative bacilli of the genus *Proteus*, most commonly *Proteus mirabilis*. Read more about Proteus bronchitis
7 drugs 7 manufacturers
Drugs that treat it
Common Proteus bronchitis therapies.
AZTREONAM
SEPSIS CAUSED BY ENTEROBACTER·+57
APP/PREMIERPRO
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
APP/NOVAPLUS
AZTREONAM
SEPSIS CAUSED BY ENTEROBACTER·+57
APP/FRESENIUS K
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
Hospira
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
AZTREONAM
BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Proteus bronchitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProteus bronchitis refers to a lower respiratory tract infection characterized by acute inflammation of the tracheobronchial tree caused by Gram-negative bacilli of the genus *Proteus*, most commonly *Proteus mirabilis*.
Although bronchitis is predominantly viral, *Proteus* species act as opportunistic pathogens, primarily affecting hospitalized patients, elderly individuals, or immunocompromised hosts with structural lung disease, chronic obstructive pulmonary disease, or artificial airways.
Pathophysiologically, bacterial colonization and proliferation trigger mucosal edema, hypersecretion, and neutrophilic infiltration, clinically presenting with persistent productive cough, purulent sputum, dyspnea, and low-grade fever in the absence of radiographic evidence of pneumonia.
- nih.gov
Proteus bronchitis refers to a lower respiratory tract infection characterized by acute inflammation of the tracheobronchial tree caused by Gram-negative bacilli of the genus *Proteus*, most commonly *Proteus mirabilis* Although bronchitis is predominantly viral, *Proteus* species act as opportunistic pathogens, primarily affecting hospitalized patients, elderly individuals, or immunocompromised hosts with structural lung disease, chronic obstructive pulmonary disease, or artificial airways
- ama-assn.org
Although bronchitis is predominantly viral, *Proteus* species act as opportunistic pathogens, primarily affecting hospitalized patients, elderly individuals, or immunocompromised hosts with structural lung disease, chronic obstructive pulmonary disease, or artificial airways
- atsu.edu
Although bronchitis is predominantly viral, *Proteus* species act as opportunistic pathogens, primarily affecting hospitalized patients, elderly individuals, or immunocompromised hosts with structural lung disease, chronic obstructive pulmonary disease, or artificial airways
- mayoclinic.org
Pathophysiologically, bacterial colonization and proliferation trigger mucosal edema, hypersecretion, and neutrophilic infiltration, clinically presenting with persistent productive cough, purulent sputum, dyspnea, and low-grade fever in the absence of radiographic evidence of pneumonia
- covenanthealth.com
Pathophysiologically, bacterial colonization and proliferation trigger mucosal edema, hypersecretion, and neutrophilic infiltration, clinically presenting with persistent productive cough, purulent sputum, dyspnea, and low-grade fever in the absence of radiographic evidence of pneumonia
- lung.org
Pathophysiologically, bacterial colonization and proliferation trigger mucosal edema, hypersecretion, and neutrophilic infiltration, clinically presenting with persistent productive cough, purulent sputum, dyspnea, and low-grade fever in the absence of radiographic evidence of pneumonia
Personalize your experience
Follow Proteus bronchitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.